Is your startup a painkiller — or just a vitamin?

Investors and founders often sort products into two buckets. A painkiller solves an urgent, obvious problem the customer already knows they have — like a tool that stops your servers from crashing during a sale. A vitamin is nice to have: it might make life marginally better someday, but nobody wakes up desperate for it. Both can be good products. Only one is easy to sell.

The difference shows up in behavior, not opinion. People pull painkillers toward them: they search for a solution, sign up fast, and pay without much haggling because the pain costs them more than the price. Vitamins have to be pushed — you spend heavily on marketing to convince people they want something they were living fine without. That's why two products with similar features can have wildly different sales cycles.

The trap for beginners is that vitamins often sound more exciting in a pitch — visionary, broad, world-improving. But 'would be nice' rarely opens a wallet. A blunt test: if you took your product away tomorrow, would customers be mildly annoyed, or would their day genuinely break? The louder the complaint, the closer you are to a painkiller.

Many durable companies eventually add vitamin-like features, but they usually earn the right by first curing a real pain and getting paid for it.